Vertex Pharmaceuticals, Inc (VRTX) has a current stock price of $391.16. During the previous trading session, the stock witnessed a notable rise, reaching a high of $624.0 after opening at $393.43. The stock’s low for the day was $330.0, and it eventually closed at $472.27.
Vertex Pharmaceuticals, Inc’s stock market performance has been somewhat irregular.
52-week price history of VRTX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Vertex Pharmaceuticals, Inc’s current trading price is -24.76% away from its 52-week high, while its distance from the 52-week low is 3.52%. The stock’s price range during this period has fluctuated between $377.85 and $519.88. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 5.39 million for the day, which was evidently higher than the average daily volume of 1.53 million over the last three months.
Financial Performance and Market Capitalization
Vertex Pharmaceuticals, Inc (VRTX) has experienced a quarterly decline of -21.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 100.45B and boasts a workforce of 6100 employees.
Analysts’ Ratings For Vertex Pharmaceuticals, Inc
As of right now, 16 analysts are rating Vertex Pharmaceuticals, Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 13 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 467.10, with a change in price of -105.85. Similarly, Vertex Pharmaceuticals, Inc recorded 1,581,092 in trading volume during the last 100 days, posting a change of -21.36%.
VRTX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VRTX stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.09.
VRTX Stock Stochastic Average
Vertex Pharmaceuticals, Inc’s raw stochastic average for the past 50 days is currently at 4.55%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 4.55%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 30.91% and 30.70%, respectively.
VRTX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -22.66% this year. Over the last six months, there has been a stronger performance of -16.84%. The price of VRTX leaped by -14.86% during the last 30 days period. For the last 5-days stocks have slided -16.49%.
